Prospective, Monocentric Study to Assess Stability of a polished, tapered cemented short stem used for Total Hip Arthroplasty

Medacta Australia Pty Ltd0 个研究点目标入组 30 人开始时间: 2021年5月26日最近更新: 2021年6月7日

适应症

试验速览

暂无简介。

•Patients that have had a diagnosis of end-stage primary osteoarthritis who are eligible for primary total hip arthroplasty procedure
•-Patients assessed as being suitable for implant of the X-acta straight cemented short stem according to the indications for use (on-label)
•-Adults aged between 18 and 75 years at the time of registration
•-Ability to give informed consent
•-Patients who are informed of the conditions of the study and are willing to participate for the length of the prescribed follow-up period

•Patients with Rheumatoid Arthritis
•-Patients with a history of active infection
•-Patients who experienced an adverse event post-surgery deemed to be unrelated to device implant
•-Patients suffering a congenital or developmental abnormality of the hip joint
•-Patients who experienced a perioperative fracture
•-Patients who have had prior surgery on the hip that has been operated on
•-Patients with a history or are currently being treated for psychiatric illness/mental disorder or have a cognitive impairment
•-Patients who are highly dependent on medical care who may be unable to give consent
•-Patients with a history or are currently being treated for alcohol or drug abuse

发起方